Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date of earliest event reported): April
9, 2007
PRESTIGE
BRANDS HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Delaware
60; 001-32433 &#
160;
20-1297589
(State
or other
jurisdiction (Commission
File
Number)
(IRS
Employer
of
incorporation)
Identification
No.)
90
North Broadway, Irvington, New York 10533
(Address
of principal executive offices, including Zip Code)
(914)
524-6810
(Registrant’s
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[
]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
[
]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
2.02 Results of Operations and Financial Condition.
On
April
9, 2007, Prestige Brands Holdings, Inc. (the ‘‘Registrant’’) issued a press
release disclosing certain revenue information regarding the fiscal quarter
and
year ended March 31, 2007. A copy of that press release is attached hereto
as
Exhibit 99.1 and incorporated herein by reference.
The
information in this Form 8-K and Exhibit 99.1 attached hereto shall not be
deemed to be ‘‘filed’’ for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that section,
unless the Registrant specifically states that the information is to be
considered “filed” under the Securities Exchange Act of 1934 or incorporates it
by reference into a filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934.
Item
7.01. Regulation FD Disclosure.
The
information set forth in Item 2.02 above is incorporated by reference as if
fully set forth herein.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
|
Exhibit
|
|
Description
|
|
99.1
|
|
Press
Release dated April 9, 2007 (furnished
only).
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
April 9, 2007 PRESTIGE
BRANDS HOLDINGS, INC.
By:
/s/
Peter J. Anderson
Name:
Peter J. Anderson
Title:
Chief Financial Officer
EXHIBIT
INDEX
|
Exhibit
|
|
Description
|
|
99.1
|
|
Press
Release dated April 9, 2007 (furnished
only).
|
EXHIBIT
99.1
PRESTIGE
BRANDS HOLDINGS, INC. ANTICIPATES FOURTH QUARTER REVENUES
BELOW PRIOR YEAR, FULL YEAR FY’07 REVENUES UP
Q4
and
FY’07 Earnings Announcement & Conference Call Scheduled for May 9,
2007
Irvington,
NY, April 9, 2007—Prestige Brands Holdings, Inc. (NYSE-PBH) announced today that
revenues for the fourth quarter of fiscal 2007, ending on March 30, 2007, are
expected to be lower than the prior year comparable quarter, but higher for
the
full fiscal year compared to the prior fiscal year on both a total and organic
basis.
The
decrease in revenues for the fourth fiscal quarter is largely attributable
to
the previously announced weaker than expected cough/cold season which resulted
in lower sales in one of its key categories, as well as continued declining
revenues in the Company’s Personal Care segment.
Mark
Pettie, Chairman and Chief Executive Officer said, “Despite the fourth quarter
sales performance, full year net revenue growth should be in the mid single
digit range, with organic growth up approximately 1%. Based upon our increased
focus on driving distribution, innovation and optimized marketing across key
segments of our portfolio, at this point we continue to be comfortable with
our
previously stated long term average organic revenue growth projections of 3-4%”.
The
Company expects to release its fourth quarter and year end results on May 9,
2007, before the opening of the market, and host a conference call and web
cast
to review the results at 10AM EDT that same morning. Details will be announced
at the end of April.
About
Prestige Brands Holdings, Inc.
Located
in Irvington, New York, Prestige Brands Holdings, Inc. is a marketer and
distributor of brand name over-the-counter products, personal care and household
products sold throughout the U.S. and Canada. Key brands include Compound W®
wart remover, Chloraseptic® sore throat treatment, New-Skin® liquid bandage,
Clear eyes® and Murine® eye care products, Little Remedies® pediatric
over-the-counter products, Cutex® nail polish remover, Comet® and Spic and Span®
household products, and other well-known brands.
Forward
Looking Statements
Note:
This news release contains "forward-looking statements" within the meaning
of
the federal securities laws and is intended to qualify for the Safe Harbor
from
liability established by the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" generally can be identified by the use of
forward-looking terminology such as "assumptions," "target," "guidance,"
"outlook," "plans," "projection," "may," "will," "would," "expect," "intend,"
"estimate," "anticipate," "believe, "potential," or "continue" (or the negative
or other derivatives of each of these terms) or similar terminology. The
"forward-looking statements" include, without limitation, statements regarding
the outlook for Prestige Brands Holdings' market and the demand for its
products, earnings per share, future cash flows from operations, future revenues
and margin requirement and expansion, the success of new product introductions,
growth in costs and expenses, and the impact of acquisitions, divestitures,
restructurings and other unusual items, including Prestige Brands Holdings'
ability to integrate and obtain the anticipated results and synergies from
its
acquisitions. These projections and statements are based on management's
estimates and assumptions with respect to future events and financial
performance and are believed to be reasonable, though are inherently uncertain
and difficult to predict. Actual results could differ materially from those
projected as a result of certain factors. A discussion of factors that could
cause results to vary is included in the Company's Annual Report on Form 10-K
and other periodic and other reports filed with the Securities and Exchange
Commission.
Contact:
Dean Siegal
914-524-6819